Works matching IS 17588340 AND DT 2024

Results: 217
    1
    2
    3
    4

    Exploratory analysis of immunomodulatory factors identifies L1CAM as a prognostic marker in alveolar soft-part sarcoma.

    Published in:
    Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241293951
    By:
    • Mondaza-Hernandez, José L.;
    • Hindi, Nadia;
    • Fernandez-Serra, Antonio;
    • Ramos, Rafael;
    • Gonzalez-Cámpora, Ricardo;
    • Gómez-Mateo, María Carmen;
    • Martinez-Trufero, Javier;
    • Lavernia, Javier;
    • Lopez-Pousa, Antonio;
    • Laínez, Nuria;
    • Martinez-Garcia, Jeronimo;
    • Valverde, Claudia;
    • Vaz-Salgado, María Ángeles;
    • Garcia-Plaza, Gabriel;
    • Marin-Borrero, Isabel;
    • Carrillo-Garcia, Jaime;
    • Martin-Ruiz, Marta;
    • Romero, Pablo;
    • Gutierrez, Antonio;
    • López-Guerrero, Jose A.
    Publication type:
    Article
    5

    Abemaciclib combined with endocrine therapy as adjuvant treatment for hormone-receptor-positive, HER2−, high-risk early breast cancer: 5-year Chinese population analysis of the phase III randomized monarchE study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241286775
    By:
    • Zhang, Qingyuan;
    • Shen, Kunwei;
    • Song, Chuan-gui;
    • Ouyang, Quchang;
    • Liu, Zhenzhen;
    • Liu, Qiang;
    • Feng, Jifeng;
    • Chiu, Joanne W. Y.;
    • Tang, Jinhai;
    • Jiang, Zefei;
    • Tseng, Ling-Ming;
    • Wang, Xiaojia;
    • Yang, Liu;
    • Qian, Chenxi;
    • Shao, Zhimin
    Publication type:
    Article
    6
    7

    Analysis of outcomes in resected early-stage NSCLC with rare targetable driver mutations.

    Published in:
    Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241308466
    By:
    • Ghazali, Nadia;
    • Feng, Jamie;
    • Hueniken, Katrina;
    • Khan, Khaleeq;
    • Balaratnam, Karmugi;
    • Waddell, Thomas K.;
    • Yasufuku, Kazuhiro;
    • Pierre, Andrew;
    • Donahoe, Laura;
    • Wakeam, Elliot;
    • Cypel, Marcelo;
    • Yeung, Jonathan;
    • Keshavjee, Shaf;
    • de Perrot, Marc;
    • Leighl, Natasha B.;
    • Liu, Geoffrey;
    • Bradbury, Penelope A.;
    • Sacher, Adrian;
    • Eng, Lawson;
    • Stockley, Tracy
    Publication type:
    Article
    8
    9
    10

    Femoral bone metastasis is a poor prognostic factor in EGFR-TKIs-treated patients with EGFR -mutated non-small-cell lung cancer: a retrospective, multicenter cohort study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241303090
    By:
    • Tanaka, Ichidai;
    • Hori, Kazumi;
    • Koyama, Junji;
    • Gen, Soei;
    • Morise, Masahiro;
    • Kodama, Yuta;
    • Matsui, Akira;
    • Miyazawa, Ayako;
    • Hase, Tetsunari;
    • Hibino, Yoshitaka;
    • Yokoyama, Toshihiko;
    • Kimura, Tomoki;
    • Yoshida, Norio;
    • Sato, Mitsuo;
    • Ishii, Makoto
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    UFO registry: final analysis of baseline data from patients with advanced prostate cancer in Asia.

    Published in:
    Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241293393
    By:
    • Ye, Dingwei;
    • Kanesvaran, Ravindran;
    • Chiong, Edmund;
    • Lojanapiwat, Bannakij;
    • Pu, Yeong-Shiau;
    • Rawal, Sudhir Kumar;
    • Aik, Ong Teng;
    • Zeng, Hao;
    • Chung, Byung Ha;
    • Ashani, Md Yusoff Noor;
    • Ohyama, Chikara;
    • Kim, Choung Soo;
    • Hu, Zhiquang;
    • Tsai, Yuh-Shyan;
    • Razack, Azad Hassan Abdul;
    • Singh, Anildeep;
    • Liu, Yanfang;
    • Uemura, Hirotsugu
    Publication type:
    Article
    30

    Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience: invasive mucinous or non-mucinous lepidic adenocarcinoma of the lung (formerly bronchioloalveolar carcinoma).

    Published in:
    Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241293401
    By:
    • Chae, Young Kwang;
    • Othus, Megan;
    • Patel, Sandip Pravin;
    • Gerber, David E.;
    • Tanvetyanon, Tawee;
    • Kim, Hye Sung;
    • Chung, Liam Il-Young;
    • McLeod, Christine M.;
    • Lopez, Gabby;
    • Chen, Helen X.;
    • Sharon, Elad;
    • Streicher, Howard;
    • Ryan, Cristopher W.;
    • Blanke, Charles D.;
    • Kurzrock, Razelle
    Publication type:
    Article
    31
    32
    33
    34
    35

    Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241297092
    By:
    • Lin, Yu;
    • Shen, Wenbin;
    • Ye, Jinjun;
    • Luo, Honglei;
    • Zhang, Xizhi;
    • Xu, Yuanji;
    • Lin, Qin;
    • Liu, Wenyang;
    • Zhang, Yingying;
    • Xu, Yujin;
    • Jiang, Wei;
    • Zhao, Lina;
    • Liu, Anwen;
    • Wu, Lei;
    • Ge, Hong;
    • Xie, Conghua;
    • Zhao, Kuaile;
    • Chen, Junqiang;
    • Wang, Luhua;
    • Liu, Qi
    Publication type:
    Article
    36
    37
    38

    Comprehensive geriatric assessment guided radiotherapy in elderly patients with locally advanced rectal cancer—exploratory results on nonoperative cohort of a multicenter prospective study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241296386
    By:
    • Yang, Yue-Xin;
    • Tang, Yuan;
    • Li, Ning;
    • Tang, Yu;
    • Cheng, Yun-Jie;
    • Yang, Lin;
    • Fang, Hui;
    • Lu, Ning-Ning;
    • Qi, Shu-Nan;
    • Chen, Bo;
    • Wang, Shu-Lian;
    • Song, Yong-Wen;
    • Liu, Yue-Ping;
    • Li, Ye-Xiong;
    • Liu, Zheng;
    • Liang, Jian-Wei;
    • Zhang, Hai-Zeng;
    • Zhou, Hai-Tao;
    • Wang, Jun;
    • Liu, Wen-Yang
    Publication type:
    Article
    39

    SUNLAND: a randomized, double-blinded phase II GERCOR trial of sunitinib versus placebo and lanreotide in patients with advanced progressive midgut neuroendocrine tumors.

    Published in:
    Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241290140
    By:
    • Hammel, Pascal;
    • Smith, Denis;
    • Afchain, Pauline;
    • Dominguez-Tinajero, Sophie;
    • Seitz, Jean-François;
    • Lievre, Astrid;
    • Van Cutsem, Eric;
    • Assenat, Eric;
    • Di Fiore, Frédéric;
    • Peeters, Marc;
    • Sobhani, Iradj;
    • Raymond, Eric;
    • Charton, Emilie;
    • Vernerey, Dewi;
    • De Mestier, Louis;
    • Lombard-Bohas, Catherine
    Publication type:
    Article
    40
    41
    42
    43
    44
    45

    Therapy-relevant MDM2 amplification in cholangiocarcinomas in Caucasian patients.

    Published in:
    Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241288123
    By:
    • Lyu, Su Ir;
    • Plum, Patrick Sven;
    • Fretter, Caroline;
    • Simon, Adrian Georg;
    • Bedau, Tillmann;
    • Knipper, Karl;
    • Thomas, Michael N.;
    • Stippel, Dirk;
    • Wagner, Britta Janina;
    • Bruns, Christiane;
    • Waldschmidt, Dirk;
    • Büttner, Reinhard;
    • Drebber, Uta;
    • Quaas, Alexander
    Publication type:
    Article
    46
    47
    48
    49

    Bioinformatic and clinical experimental assay uncovers resistance and susceptibility mechanisms of human glioblastomas to temozolomide and identifies new combined and individual survival biomarkers outperforming MGMT promoter methylation.

    Published in:
    Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241292269
    By:
    • Modestov, Alexander;
    • Zolotovskaia, Marianna;
    • Suntsova, Maria;
    • Zakharova, Galina;
    • Seryakov, Aleksander;
    • Jovcevska, Ivana;
    • Mlakar, Jernej;
    • Poddubskaya, Elena;
    • Moisseev, Aleksey;
    • Vykhodtsev, Grigory;
    • Roumiantsev, Sergey;
    • Sorokin, Maksim;
    • Tkachev, Victor;
    • Simonov, Aleksander;
    • Buzdin, Anton
    Publication type:
    Article
    50